Non-polio enteroviruses among healthy children in the Philippines.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
03 Feb 2020
Historique:
received: 15 08 2019
accepted: 27 01 2020
entrez: 5 2 2020
pubmed: 6 2 2020
medline: 16 5 2020
Statut: epublish

Résumé

Enteroviruses (EVs) are most commonly associated with either mild or asymptomatic infections, however, the presence of silent carriers in the community has been proven to play a crucial role in the spread of diseases such as hand, foot, and mouth disease (HFMD) that records high incidence in Asia Pacific region. In the Philippines, limited information is available on the etiology and prevalence of enterovirus outside the Acute Flaccid Paralysis (AFP) surveillance, thus, a study to determine the baseline prevalence of Non-Polio Enteroviruses (NPEVs) among healthy Filipino children was conducted. A descriptive, cross-sectional study was performed to determine the prevalence of NPEV among healthy children under 6 years old in the Philippines. Duplicate stool samples were collected from 360 healthy children residing in three major urban cities in the country. Virus isolation and polymerase chain reaction were performed to identify enteroviruses present in the samples. To determine if the results of the study are comparable to the AFP surveillance data, the results of the study were compared to the prevalence and isolation rate among AFP cases of the similar cases collected the same year. Prevalence of enteroviruses among healthy children was found to be at 24.7%. Comparing the NPEV rates from the study and AFP surveillance of similar age and the same year of collection, there was no significant difference in NPEV case prevalence. The study identified a total of 19 different enterovirus serotypes with majority belonging to species Enterovirus B (EV-B). The study was able to establish a baseline NPEV case prevalence of 24.7% among healthy children aged under 6 years old in three major urban sites in the Philippines. The high isolation of NPEV among healthy children signifies continuous fecal-oral transmission of enteroviruses in the community.

Sections du résumé

BACKGROUND BACKGROUND
Enteroviruses (EVs) are most commonly associated with either mild or asymptomatic infections, however, the presence of silent carriers in the community has been proven to play a crucial role in the spread of diseases such as hand, foot, and mouth disease (HFMD) that records high incidence in Asia Pacific region. In the Philippines, limited information is available on the etiology and prevalence of enterovirus outside the Acute Flaccid Paralysis (AFP) surveillance, thus, a study to determine the baseline prevalence of Non-Polio Enteroviruses (NPEVs) among healthy Filipino children was conducted.
METHODS METHODS
A descriptive, cross-sectional study was performed to determine the prevalence of NPEV among healthy children under 6 years old in the Philippines. Duplicate stool samples were collected from 360 healthy children residing in three major urban cities in the country. Virus isolation and polymerase chain reaction were performed to identify enteroviruses present in the samples. To determine if the results of the study are comparable to the AFP surveillance data, the results of the study were compared to the prevalence and isolation rate among AFP cases of the similar cases collected the same year.
RESULTS RESULTS
Prevalence of enteroviruses among healthy children was found to be at 24.7%. Comparing the NPEV rates from the study and AFP surveillance of similar age and the same year of collection, there was no significant difference in NPEV case prevalence. The study identified a total of 19 different enterovirus serotypes with majority belonging to species Enterovirus B (EV-B).
CONCLUSION CONCLUSIONS
The study was able to establish a baseline NPEV case prevalence of 24.7% among healthy children aged under 6 years old in three major urban sites in the Philippines. The high isolation of NPEV among healthy children signifies continuous fecal-oral transmission of enteroviruses in the community.

Identifiants

pubmed: 32013921
doi: 10.1186/s12889-020-8284-x
pii: 10.1186/s12889-020-8284-x
pmc: PMC6998086
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : World Health Organization
ID : Not Applicable
Pays : International
Organisme : National Institute of Health, KCDC
ID : 4845-300

Références

BMC Infect Dis. 2019 May 2;19(1):370
pubmed: 31046684
PLoS One. 2013 Apr 22;8(4):e61650
pubmed: 23630606
Mol Med Rep. 2014 Dec;10(6):2811-8
pubmed: 25241846
PLoS One. 2013 Jun 06;8(6):e64889
pubmed: 23762262
Neurohospitalist. 2014 Oct;4(4):223-9
pubmed: 25360208
J Clin Microbiol. 1988 Jul;26(7):1298-303
pubmed: 2842370
Virology. 1995 Sep 10;212(1):30-8
pubmed: 7676647
Trends Endocrinol Metab. 2018 Mar;29(3):137-139
pubmed: 29326001
Virol J. 2015 Jun 03;12:83
pubmed: 26036928
J Med Virol. 2012 Jun;84(6):923-30
pubmed: 22499016
J Med Virol. 2008 Apr;80(4):670-9
pubmed: 18297723
J Infect Dis. 2014 Nov 1;210 Suppl 1:S252-8
pubmed: 25316843
J Virol. 2005 Oct;79(20):12650-7
pubmed: 16188967
Medicine (Baltimore). 2018 Aug;97(31):e11610
pubmed: 30075535
Emerg Infect Dis. 2011 Aug;17(8):1537-40
pubmed: 21801645
J Gen Virol. 2017 Oct;98(10):2421-2422
pubmed: 28884666
PLoS One. 2014 Apr 28;9(4):e96051
pubmed: 24776922
BMC Infect Dis. 2013 Dec 27;13:606
pubmed: 24370001
J Med Virol. 2012 Apr;84(4):624-31
pubmed: 22337302
J Med Virol. 2013 Jan;85(1):116-20
pubmed: 23124895
J Clin Microbiol. 1988 Dec;26(12):2576-80
pubmed: 2852672
Int Health. 2017 May 1;9(3):156-163
pubmed: 28582560
J Virol. 1999 Mar;73(3):1941-8
pubmed: 9971773
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Pan Afr Med J. 2014 May 19;18:66
pubmed: 25400833
Virus Genes. 2012 Oct;45(2):207-17
pubmed: 22743820
PLoS One. 2017 Jul 13;12(7):e0181234
pubmed: 28704524
J Clin Microbiol. 1999 May;37(5):1288-93
pubmed: 10203472

Auteurs

Maria Melissa Ann Jiao (MMA)

National Polio Laboratory, Department of Virology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines.

Lea Necitas Apostol (LN)

National Polio Laboratory, Department of Virology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines.

Maricel de Quiroz-Castro (M)

World Health Organization Country Office, Manila, Philippines.

Youngmee Jee (Y)

Center for Infectious Disease Research, National Institute of Health, Korea Center for Disease Control and Prevention, Cheongju, Chungcheongbuk-do, South Korea.

Vito Roque (V)

Department of Health-Epidemiology Bureau, Manila, Philippines.

Manuel Mapue (M)

Department of Health-Center for Health Development NCR, Mandaluyong City, Philippines.

Frances Marsha Navarro (FM)

Department of Health-Center for Health Development Region VII, Cebu City, Philippines.

Cleo Fe Tabada (CF)

Department of Health-Center for Health Development Region XI, Davao City, Philippines.

Amado Tandoc (A)

National Polio Laboratory, Department of Virology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines. amado.tandocMD@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH